1Moore LJ,Mckinley BA,Turner KL. The epidemiology of sepsis in general surgery patients[J].Journal of Trauma-Injury Infection and Critical Care,2011,(03):672-680.
2Bone RC,Balk RA,Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Chest,1992,(06):1644-1655.
3Levy MM,Fink MP,Marshall JC. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference[J].Intensive Care Medicine,2003,(04):530-538.
4Dellinger RP,Levy MM,Rhodes A. Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2012[J].Critical Care Medicine,2013,(02):580-637.
5Dellinger RP,Levy MM,Carlet JM. Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2008[J].Intensive Care Medicine,2008,(01):17-60.doi:10.1007/s00134-007-0934-2.
6Campbell ML,Marchaim D,Pogue JM. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin:old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents[J].Annals of Pharmacotherapy,2012,(12):1587-1597.
7Schwaber M J,Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia:a systematic review and meta-analysis[J].Journal of Antimicrobial Chemotherapy,2007,(05):913-920.
8Kang CI,Song JH,Chung DR. Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection:a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort[J].Journal of Infection,2010,(04):299-306.
9Davies B,Cohen J. Endotoxin removal devices for the treatment of sepsis and septic shock[J].Lancet Infectious Diseases,2011,(01):65-71.
10Barb AW,Jiang L,Raetz C R. Assignment of 1 H,13C and 15N backbone resonances of Escherichia coli LpxC bound to L-161,240[J].Biomol NMR Assign,2010,(01):37-40.
